Results 51 to 60 of about 13,239,682 (316)

Short chain fatty acids-producing and mucin-degrading intestinal bacteria predict the progression of early Parkinson’s disease

open access: yesnpj Parkinson's Disease, 2022
To elucidate the relevance of gut dysbiosis in Parkinson’s disease (PD) in disease progression, we made random forest models to predict the progression of PD in two years by gut microbiota in 165 PD patients.
Hiroshi Nishiwaki   +12 more
semanticscholar   +1 more source

Drosophila as a Model Organism in Host–Pathogen Interaction Studies

open access: yesFrontiers in Cellular and Infection Microbiology, 2020
Owing to the genetic similarities and conserved pathways between a fruit fly and mammals, the use of the Drosophila model as a platform to unveil novel mechanisms of infection and disease progression has been justified and widely instigated.
Salma Younes   +4 more
doaj   +1 more source

Predicting Severe Disease and Critical Illness on Initial Diagnosis of COVID-19: Simple Triage Tools

open access: yesFrontiers in Medicine, 2022
RationaleThis study was conducted to develop, validate, and compare prediction models for severe disease and critical illness among symptomatic patients with confirmed COVID-19.MethodsFor development cohort, 433 symptomatic patients diagnosed with COVID ...
Lutfi Ali S. Kurban   +7 more
doaj   +1 more source

Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis

open access: yesAmerican Journal of Respiratory and Critical Care Medicine, 2019
Rationale: Idiopathic pulmonary fibrosis (IPF) causes considerable global morbidity and mortality, and its mechanisms of disease progression are poorly understood. Recent observational studies have reported associations between lung dysbiosis, mortality,
D. O’Dwyer   +17 more
semanticscholar   +1 more source

Deep recurrent model for individualized prediction of Alzheimer's disease progression

open access: yesNeuroImage, 2020
Alzheimer's disease (AD) is known as one of the major causes of dementia and is characterized by slow progression over several years, with no treatments or available medicines. In this regard, there have been efforts to identify the risk of developing AD
Wonsik Jung   +3 more
semanticscholar   +1 more source

Biomarkers of Disease Progression [PDF]

open access: yes, 2012
After being informed about a diagnosis of multiple sclerosis (MS), patients are often concerned about the risk of disease progression and future prognosis. Many are naturally concerned over the future course, severity of the disease, and likely disability.
openaire   +4 more sources

Progression of Liver Diseases [PDF]

open access: yesHepatitis Monthly, 2012
Dear Editor, To date, the knowledge on the natural history of HCV infection and the risk factors associated with progression of liver disease in children is limited. Progressive liver disease, including hepatocellular carcinoma, is rare but has been reported [1].
openaire   +2 more sources

Apathy in Alzheimer's disease: Contribution to a clinical view on progression of dementia

open access: yesDementia & Neuropsychologia
In addition to cognitive impairment, apathy is increasingly recognized as an important neuropsychiatric syndrome in Alzheimer's disease (AD). Aims: To identify the relationship between dementia severity and apathy levels, and to discuss the association ...
Florindo Stella   +5 more
doaj   +1 more source

Measuring coral disease lesions: a comparison of methodologies

open access: yesFrontiers in Marine Science
The presence of stressors, particularly disease, on corals necessitates assessments of their severity in order to compare threat levels and to plan for impacts. Diseases in particular are often measured via the rate at which a lesion moves across a coral
Karen L. Neely
doaj   +1 more source

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen   +23 more
wiley   +1 more source

Home - About - Disclaimer - Privacy